Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$17.23 - $21.71 $106,912 - $134,710
-6,205 Reduced 22.56%
21,298 $425,000
Q1 2023

Apr 13, 2023

BUY
$18.08 - $24.55 $15,331 - $20,818
848 Added 3.18%
27,503 $520,000
Q4 2022

Jan 18, 2023

BUY
$20.4 - $24.73 $10,587 - $12,834
519 Added 1.99%
26,655 $0
Q3 2022

Oct 20, 2022

BUY
$22.29 - $35.04 $582,571 - $915,805
26,136 New
26,136 $691,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.